Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.

@article{Piana2011ToxicitiesAR,
  title={Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.},
  author={Peachy Mae T. Piana and Carin F. Gonsalves and Takami Sato and Pramila Rani Ann{\'e} and Jeffrey W. McCann and Voichita Bar Ad and David J. Eschelman and Laurence Parker and Laura A. Doyle and Daniel B Brown},
  journal={Journal of vascular and interventional radiology : JVIR},
  year={2011},
  volume={22 10},
  pages={1373-9}
}
PURPOSE To report the incidence of liver function test (LFT) toxicities after radioembolization with yttrium-90 ((90)Y) SIR-Spheres and review potential risk factors. MATERIALS AND METHODS Patients receiving (90)Y for radioembolization of primary or metastatic liver tumors had follow-up LFTs 29-571 days after treatment. The incidence and duration of bilirubin, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) toxicities were documented using common terminology criteria… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…